A Zoom screenshot of Stacey talking with Dexcom's Jake Leach

“We’re focused on bringing more access” Dexcom talks Medicare, G7 updates and more

[podcast src=”https://html5-player.libsyn.com/embed/episode/id/26703687/height/90/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/26a9e0/” width=”100%” scrolling=”no” class=”podcast-class” frameborder=”0″ placement=”top” primary_content_url=”http://traffic.libsyn.com/diabetesconnections/Ep_563_Final_Dexcom_Medicare_Leach.mp3″ libsyn_item_id=”26703687″ height=”90″ theme=”custom” custom_color=”26a9e0″ player_use_thumbnail=”use_thumbnail” use_download_link=”use_download_link” download_link_text=”Download” /]Medicare has now expanded coverage for CGM use among people with type 2, in part because of studies by companies like Dexcom. We’ll talk about those findings and learn more about the US release of the G7. Dexcom Chief Operating…